ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,074Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1499

$1.44M Total Retail Price of All Prescriptions

Rank: 25 out of 1499

604 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 604 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 604 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 19,349 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 1,074 672 S3 1 4
OMEPRAZOLE 1,001 756 2 5
METOPROLOL TARTRATE 840 617 3 10
FUROSEMIDE 829 614 4 7
LEVOTHYROXINE SODIUM 788 656 5 2
GABAPENTIN 787 553 6 13
SIMVASTATIN 666 532 7 3
WARFARIN SODIUM 545 446 8 12
POTASSIUM CHLORIDE 518 418 9 11
CRESTOR 491 313 10 34
AMLODIPINE BESYLATE 433 345 11 6
METFORMIN HCL 425 231 12 8
LISINOPRIL 422 329 13 1
DIOVAN 404 309 14 58
CITALOPRAM HBR 385 269 15 14
PREDNISONE 373 281 16 42
ISOSORBIDE MONONITRATE ER 343 237 17 51
CYMBALTA 319 191 18 40
LOVASTATIN 318 279 19 19
TAMSULOSIN HCL 297 249 20 29
SPIRONOLACTONE 287 190 21 61
ATENOLOL 283 254 22 21
CLOPIDOGREL 251 190 23 39
RANITIDINE HCL 250 137 24 15
LANTUS 239 173 25 46
JANUVIA 236 138 26 84
METFORMIN HCL ER 231 185 27 53
CEFDINIR 230 148 28 187
CARVEDILOL 230 184 28 22
NEXIUM 225 142 30 28
FLUTICASONE PROPIONATE 219 112 31 31
CEPHALEXIN 211 160 32 83
SPIRIVA 208 119 33 44
LOSARTAN POTASSIUM 208 161 33 26
TRAMADOL HCL 207 163 35 16
LOVAZA 206 114 36 136
ADVAIR DISKUS 205 138 37 37
ATORVASTATIN CALCIUM 198 140 38 17
TIZANIDINE HCL 193 121 39 105
DIOVAN HCT 193 160 39 122
PLAVIX 191 143 41 54
POLYETHYLENE GLYCOL 3350 189 134 42 52
HYDROCHLOROTHIAZIDE 175 145 43 9
INSULIN SYRINGE 167 118 44 102
ENALAPRIL MALEATE 167 106 44 75
ALLOPURINOL 162 100 46 36
NIASPAN 160 91 47 150
DILTIAZEM 24HR CD 159 159 48 82
VOLTAREN 159 120 48 210
PROAIR HFA 156 72 50 30
DIGOXIN 151 142 51 56
SINGULAIR 147 85 52 67
LEVOTHROID 141 122 53 233
COLCRYS 138 91 54 267
ZETIA 136 105 55 91
AMITRIPTYLINE HCL 125 78 R 56 49
NYSTATIN 120 82 57 146
SERTRALINE HCL 120 85 57 24
NAPROXEN 118 27 59 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 117 93 60 87
PEN NEEDLE 117 70 60 120
RISPERIDONE 116 71 62 74
MIRTAZAPINE 114 114 63 50
TRAMADOL HCL-ACETAMINOPHEN 112 97 64 162
AMLODIPINE BESYLATE-BENAZEPRIL 111 52 65 109
TERAZOSIN HCL 109 88 66 147
NAMENDA 108 108 67 47
METOPROLOL SUCCINATE 103 85 68 20
LIDODERM 100 72 69 123
FINASTERIDE 100 92 69 98
MONTELUKAST SODIUM 97 66 71 133
LIPITOR 96 53 72 107
LANTUS SOLOSTAR 91 56 73 89
TRICOR 88 49 74 103
GLIMEPIRIDE 88 32 74 38
PRENATAL PLUS 88 44 74 157
OXYBUTYNIN CHLORIDE 88 77 74 95
FLUOXETINE HCL 88 80 74 43
XOPENEX HFA 88 54 74 199
ROPINIROLE HCL 87 47 80 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 77 81 25
NOVOLOG 82 54 82 110
GLYBURIDE 82 71 R 82 69
IBUPROFEN 82 34 82 70
ZOLPIDEM TARTRATE 81 56 85 23
HYDRALAZINE HCL 81 77 85 118
ALENDRONATE SODIUM 81 68 85 33
LEVOFLOXACIN 79 61 88 101
LYRICA 78 35 89 90
CYCLOBENZAPRINE HCL 77 49 R 90 41
MELOXICAM 76 72 91 27
ESCITALOPRAM OXALATE 75 71 92 76
TRAZODONE HCL 73 37 93 32
NITROGLYCERIN PATCH 73 46 93 250
LOSARTAN-HYDROCHLOROTHIAZIDE 71 61 95 73
VYTORIN 69 33 96 154
GLYBURIDE-METFORMIN HCL 68 40 R 97 165
CLONIDINE HCL 68 53 97 57
SPIRONOLACTONE-HCTZ 68 47 97 237
DETROL LA 66 50 100 155
DIVALPROEX SODIUM 65 32 101 100
DOXYCYCLINE HYCLATE 65 43 101 106
BENAZEPRIL HCL 63 63 103 93
COMBIVENT 63 28 103 78
CIPROFLOXACIN HCL 63 56 103 65
PHENYTOIN SODIUM EXTENDED 62 46 106 137
VENTOLIN HFA 62 37 106 148
PANTOPRAZOLE SODIUM 60 29 108 48
AZITHROMYCIN 59 41 109 45
PROMETHAZINE HCL 59 25 R 109 138
MUPIROCIN 58 37 111 177
LACTULOSE 58 53 111 181
MECLIZINE HCL 58 49 111 186
NOVOLOG FLEXPEN 56 16 114 207
PRAVASTATIN SODIUM 55 53 115 18
METOCLOPRAMIDE HCL 54 28 116 114
SYNTHROID 53 43 117 68
GLIPIZIDE 51 32 118 64
DONEPEZIL HCL 50 50 119 35
DILTIAZEM HCL 50 43 119 239
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.